Cullinan Oncology takes in $150 mln Series A
Cullinan Oncology LLC, a developer of cancer treatments, has raised $150 million in Series A financing. UBS Oncology Impact Fund managed by MPM Capital and F2 Ventures led the round.
3 October 2017•1 min read
